Sliman, S. M., Eubank, T. D., Kotha, S. R., Kuppusamy, M. L., Sherwani, S. I., O’Connor Butler, E. S., . . . Parinandi, N. L. (2009). Hyperglycemic oxoaldehyde, glyoxal, causes barrier dysfunction, cytoskeletal alterations, and inhibition of angiogenesis in vascular endothelial cells: Aminoguanidine protection.
Stile di citazione ChicagoSliman, Sean M., et al. Hyperglycemic Oxoaldehyde, Glyoxal, Causes Barrier Dysfunction, Cytoskeletal Alterations, and Inhibition of Angiogenesis in Vascular Endothelial Cells: Aminoguanidine Protection. 2009.
Citazione MLASliman, Sean M., et al. Hyperglycemic Oxoaldehyde, Glyoxal, Causes Barrier Dysfunction, Cytoskeletal Alterations, and Inhibition of Angiogenesis in Vascular Endothelial Cells: Aminoguanidine Protection. 2009.